Extracellular vesicles contribute to early cyst development in autosomal dominant polycystic kidney disease by cell-to-cell communication
- PMID: 37249915
- DOI: 10.1096/fj.202300490R
Extracellular vesicles contribute to early cyst development in autosomal dominant polycystic kidney disease by cell-to-cell communication
Abstract
Autosomal dominant polycystic kidney disease (ADPKD) is characterized by the formation of fluid-filled cysts within the kidney due to mutations in PKD1 or PKD2. Although the disease remains incompletely understood, one of the factors associated with ADPKD progression is the release of nucleotides (including ATP), which can initiate autocrine or paracrine purinergic signaling by binding to their receptors. Recently, we and others have shown that increased extracellular vesicle (EVs) release from PKD1 knockout cells can stimulate cyst growth through effects on recipient cells. Given that EVs are an important communicator between different nephron segments, we hypothesize that EVs released from PKD1 knockout distal convoluted tubule (DCT) cells can stimulate cyst growth in the downstream collecting duct (CD). Here, we show that administration of EVs derived from Pkd1-/- mouse distal convoluted tubule (mDCT15) cells result in a significant increase in extracellular ATP release from Pkd1-/- mouse inner medullary collecting duct (iMCD3) cells. In addition, exposure of Pkd1-/- iMCD3 cells to EVs derived from Pkd1-/- mDCT15 cells led to an increase in the phosphorylation of the serine/threonine-specific protein Akt, suggesting activation of proliferative pathways. Finally, the exposure of iMCD3 Pkd1-/- cells to mDCT15 Pkd1-/- EVs increased cyst size in Matrigel. These findings indicate that EVs could be involved in intersegmental communication between the distal convoluted tubule and the collecting duct and potentially stimulate cyst growth.
Keywords: autosomal dominant polycystic kidney disease; exosomes; extracellular vesicles; intrarenal communication; purinergic signaling.
© 2023 Federation of American Societies for Experimental Biology.
Similar articles
-
Involvement of ceramide biosynthesis in increased extracellular vesicle release in Pkd1 knock out cells.Front Endocrinol (Lausanne). 2022 Oct 10;13:1005639. doi: 10.3389/fendo.2022.1005639. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36299464 Free PMC article.
-
Cyclin-Dependent Kinase 1 Activity Is a Driver of Cyst Growth in Polycystic Kidney Disease.J Am Soc Nephrol. 2021 Jan;32(1):41-51. doi: 10.1681/ASN.2020040511. Epub 2020 Oct 12. J Am Soc Nephrol. 2021. PMID: 33046531 Free PMC article.
-
Cux1 promotes cell proliferation and polycystic kidney disease progression in an ADPKD mouse model.Am J Physiol Renal Physiol. 2017 Oct 1;313(4):F1050-F1059. doi: 10.1152/ajprenal.00380.2016. Epub 2017 Jul 12. Am J Physiol Renal Physiol. 2017. PMID: 28701314 Free PMC article.
-
Current advances in molecular genetics of autosomal-dominant polycystic kidney disease.Curr Opin Nephrol Hypertens. 2001 Jan;10(1):23-31. doi: 10.1097/00041552-200101000-00005. Curr Opin Nephrol Hypertens. 2001. PMID: 11195048 Review.
-
Cell Proliferation and Apoptosis in ADPKD.Adv Exp Med Biol. 2016;933:25-34. doi: 10.1007/978-981-10-2041-4_3. Adv Exp Med Biol. 2016. PMID: 27730432 Review.
Cited by
-
Physiologic mechanisms underlying polycystic kidney disease.Physiol Rev. 2025 Jul 1;105(3):1553-1607. doi: 10.1152/physrev.00018.2024. Epub 2025 Feb 12. Physiol Rev. 2025. PMID: 39938884 Free PMC article. Review.
References
REFERENCES
-
- Harris PC, Torres VE. Polycystic kidney disease. Annu Rev Med. 2009;60:321-337. doi:10.1146/annurev.med.60.101707.125712
-
- Paul BM, vanden Heuvel GB. Kidney: polycystic kidney disease. Wiley Interdiscip Rev Dev Biol. 2014;3(6):465-487. doi:10.1002/wdev.152
-
- Boucher C, Sandford R. Autosomal dominant polycystic kidney disease (ADPKD, MIM 173900, PKD1 and PKD2 genes, protein products known as polycystin-1 and polycystin-2). Eur J Hum Genet. 2004;12(5):347-354. doi:10.1038/sj.ejhg.5201162
-
- Ilatovskaya DV, Palygin O, Staruschenko XA. Functional and therapeutic importance of purinergic signaling in polycystic kidney disease. Am J Physiol Renal Physiol. 2016;311:1135-1139. doi:10.1152/ajprenal.00406.2016.-Polycystic
-
- Menzies RI, Tam FW, Unwin RJ, Bailey MA. Purinergic signaling in kidney disease. Kidney Int. 2017;91(2):315-323. doi:10.1016/j.kint.2016.08.029
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Miscellaneous